| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |